These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 14639656)

  • 1. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
    Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
    Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
    Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
    Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine mapping of the 11q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma.
    Lung HL; Cheng Y; Kumaran MK; Liu ET; Murakami Y; Chan CY; Yau WL; Ko JM; Stanbridge EJ; Lung ML
    Int J Cancer; 2004 Nov; 112(4):628-35. PubMed ID: 15382043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma.
    Liu XQ; Chen HK; Zhang XS; Pan ZG; Li A; Feng QS; Long QX; Wang XZ; Zeng YX
    Int J Cancer; 2003 Aug; 106(1):60-5. PubMed ID: 12794757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas.
    Heller G; Fong KM; Girard L; Seidl S; End-Pfützenreuter A; Lang G; Gazdar AF; Minna JD; Zielinski CC; Zöchbauer-Müller S
    Oncogene; 2006 Feb; 25(6):959-68. PubMed ID: 16205641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma.
    Kwong J; Lo KW; Chow LS; Chan FL; To KF; Huang DP
    Int J Cancer; 2005 Jan; 113(3):386-92. PubMed ID: 15455391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silencing of cellular retinol-binding proteins in nasopharyngeal carcinoma.
    Kwong J; Lo KW; Chow LS; To KF; Choy KW; Chan FL; Mok SC; Huang DP
    Neoplasia; 2005 Jan; 7(1):67-74. PubMed ID: 15720818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer.
    Kuramochi M; Fukuhara H; Nobukuni T; Kanbe T; Maruyama T; Ghosh HP; Pletcher M; Isomura M; Onizuka M; Kitamura T; Sekiya T; Reeves RH; Murakami Y
    Nat Genet; 2001 Apr; 27(4):427-30. PubMed ID: 11279526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma.
    Chow LS; Lo KW; Kwong J; Wong AY; Huang DP
    Oncol Rep; 2004 Oct; 12(4):781-7. PubMed ID: 15375500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOR1 is an HSF1- and NRF1-regulated putative tumor suppressor inactivated by promoter hypermethylation in nasopharyngeal carcinoma.
    Li W; Li X; Wang W; Li X; Tan Y; Yi M; Yang J; McCarthy JB; Xiong W; Wu M; Ma J; Su B; Zhang Z; Liao Q; Xiang B; Li G
    Carcinogenesis; 2011 Sep; 32(9):1305-14. PubMed ID: 21803736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
    Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
    Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines.
    Fukami T; Fukuhara H; Kuramochi M; Maruyama T; Isogai K; Sakamoto M; Takamoto S; Murakami Y
    Int J Cancer; 2003 Oct; 107(1):53-9. PubMed ID: 12925956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma.
    Ito T; Shimada Y; Hashimoto Y; Kaganoi J; Kan T; Watanabe G; Murakami Y; Imamura M
    Cancer Res; 2003 Oct; 63(19):6320-6. PubMed ID: 14559819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.
    Zhang Z; Sun D; Van do N; Tang A; Hu L; Huang G
    Int J Cancer; 2007 Jan; 120(1):32-8. PubMed ID: 17013896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs.
    Jansen M; Fukushima N; Rosty C; Walter K; Altink R; Heek TV; Hruban R; Offerhaus JG; Goggins M
    Cancer Biol Ther; 2002; 1(3):293-6. PubMed ID: 12432281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.
    Lo KW; Kwong J; Hui AB; Chan SY; To KF; Chan AS; Chow LS; Teo PM; Johnson PJ; Huang DP
    Cancer Res; 2001 May; 61(10):3877-81. PubMed ID: 11358799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.
    Agathanggelou A; Dallol A; Zöchbauer-Müller S; Morrissey C; Honorio S; Hesson L; Martinsson T; Fong KM; Kuo MJ; Yuen PW; Maher ER; Minna JD; Latif F
    Oncogene; 2003 Mar; 22(10):1580-8. PubMed ID: 12629521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines.
    Honda T; Tamura G; Waki T; Jin Z; Sato K; Motoyama T; Kawata S; Kimura W; Nishizuka S; Murakami Y
    Jpn J Cancer Res; 2002 Aug; 93(8):857-60. PubMed ID: 12716461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
    Kwong J; Lo KW; To KF; Teo PM; Johnson PJ; Huang DP
    Clin Cancer Res; 2002 Jan; 8(1):131-7. PubMed ID: 11801549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation.
    Ying J; Li H; Seng TJ; Langford C; Srivastava G; Tsao SW; Putti T; Murray P; Chan AT; Tao Q
    Oncogene; 2006 Feb; 25(7):1070-80. PubMed ID: 16247458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.